US FDA consults on applying ICH stability testing guides for new drugs to generics
This article was originally published in SRA
Executive Summary
To standardise its stability testing policies for medicines, the US Food and Drug Administration has proposed applying to generic drugs stability testing guidelines developed by the International Conference on Harmonisation for new drug products1,2.